Literature DB >> 2221603

A prospective assessment of the Garren-Edwards Gastric Bubble and bariatric surgery in the treatment of morbid obesity.

D F Kirby1, J B Wade, P R Mills, H J Sugerman, J M Kellum, A M Zfass, J V Starkey, R Birkenhauer, R M Hamer.   

Abstract

Morbid obesity is a serious medical hazard, and effective alternatives to surgery have been unsuccessful. In 1985, the Garren-Edwards Gastric Bubble (GEGB) was offered as an adjunct to dietary and behavioral therapy for weight loss treatment. The safety and efficacy of the GEGB were compared with bariatric surgery, the current standard for the treatment of morbid obesity. Fifty-seven patients received GEGB and 77 underwent bariatric surgery. GEGB patients were divided into two groups: those who attended group therapy and those who did not. This study showed that bariatric surgery was far more effective in reducing excess body weight during a 12-month period compared with the GEGB plus group therapy and the GEGB alone. The morbidity from bariatric surgery was greater than in the GEGB-treated groups, while the cost for uncomplicated cases for a year's treatment was comparable. It is concluded that the GEGB does not offer an effective alternative to bariatric surgery in the treatment of morbid obesity.

Entities:  

Mesh:

Year:  1990        PMID: 2221603

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  13 in total

1.  Treating obesity.

Authors:  J S Garrow
Journal:  BMJ       Date:  1991-04-06

2.  Functional neuroimaging of gastric distention.

Authors:  Elke Stephan; José V Pardo; Patricia L Faris; Boyd K Hartman; Suck W Kim; Emil H Ivanov; Randy S Daughters; Patricia A Costello; Robert L Goodale
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

Review 3.  Development of minimally invasive techniques for management of medically-complicated obesity.

Authors:  Farzin Rashti; Ekta Gupta; Suzan Ebrahimi; Timothy R Shope; Timothy R Koch; Christopher J Gostout
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 4.  Endoscopic treatment of obesity.

Authors:  Agnieszka Swidnicka-Siergiejko; Eugeniusz Wróblewski; Dabrowski Andrzej
Journal:  Can J Gastroenterol       Date:  2011-11       Impact factor: 3.522

5.  Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  S Sauerland; L Angrisani; M Belachew; J M Chevallier; F Favretti; N Finer; A Fingerhut; M Garcia Caballero; J A Guisado Macias; R Mittermair; M Morino; S Msika; F Rubino; R Tacchino; R Weiner; E A M Neugebauer
Journal:  Surg Endosc       Date:  2004-12-02       Impact factor: 4.584

Review 6.  Endoluminal Treatments for Obesity and Related Hypertension: Updates, Review, and Clinical Perspective.

Authors:  Courtney Cripps; Mitchell Roslin
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

7.  Safety of the Ullorex oral intragastric balloon for the treatment of obesity.

Authors:  Corby K Martin; Drake E Bellanger; Kristina K Rau; Sandra Coulon; Frank L Greenway
Journal:  J Diabetes Sci Technol       Date:  2007-07

Review 8.  Intragastric balloon for obesity.

Authors:  M Fernandes; A N Atallah; B G O Soares; S Humberto; S Guimarães; D Matos; L Monteiro; B Richter
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 9.  Advances in the Endoscopic Management of Obesity.

Authors:  Jason Behary; Vivek Kumbhari
Journal:  Gastroenterol Res Pract       Date:  2015-05-28       Impact factor: 2.260

10.  The Obalon swallowable intragastric balloon in pediatric and adolescent morbid obesity.

Authors:  Francesco De Peppo; Romina Caccamo; Ottavio Adorisio; Emanuela Ceriati; Paola Marchetti; Antonio Contursi; Arianna Alterio; Claudia Della Corte; Malnia Manco; Valerio Nobili
Journal:  Endosc Int Open       Date:  2017-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.